Using differential mRNA display to uncover potential mediators associated with chronic rejection, we identified a cDNA fragment induced in Lewis to F344 rat cardiac allografts with arteriosclerosis but not Lewis syngrafts. The full-length cDNA (1.4 kb) isolated from a rat cardiac allograft cDNA library was 99% identical to galactose/N-acetylgalactosamine (Gal/GaINAc) macrophage lectin, a cell-surface receptor. This cDNA hybridized in Northern analysis with total RNA from eight cardiac allografts but not with host hearts, syngrafts, or other organs. There was a significant allograft-specific increase in transcript levels measured by reverse transcriptase PCR at days 7, 14, 28, and 75 in comparison with paired F344 host hearts (subject to same circulation but histologically normal), day-0 hearts, and syngrafts (P < 0.008, n = 4 at each time). Transcript levels in cardiac allografts were higher than those in paired host spleens (a major source of inflammatory cells) (P < 0.0001), indicating the localized nature of Gal/GalNAc lectin induction. By in situ hybridization and immunostaining, Gal/GalNAc lectin expression localized to a subset of inflammatory cells in cardiac allografts. These findings link Gal/GalNAc macrophage lectin to the chronic rejection process, as a possible mediator of macrophage infiltration. (J.
Introduction
The major limitation to long-term survival after cardiac transplantation in humans is the development of chronic rejection ( 1 ) . It is characterized by an obliterative arteriosclerosis with progressive neointimal thickening that eventually results in ischemic injury (2, 3) . Studies of vessels from human heart transplant recipients have revealed an intimal hyperplasia that is concentric and diffuse, involves a spectrum of vessels, and is highly prevalent. The pathogenesis of transplant arteriosclerosis is unknown, and studies to elucidate the process have been limited by difficulty in obtaining useful clinical specimens: transplant arteriosclerosis occurs only in the donor heart and spares the host vessels. The leading hypothesis about the arteriosclerotic process holds that a chronic cell-mediated immune response to alloantigens produces cytokines that mediate neointimal smooth muscle cell accumulation in the graft-derived vasculature, in a manner analogous to the process of delayed-type hypersensitivity (2, 3) .
Considerable insight into the cellular evolution of transplant arteriosclerosis has been gained recently from studies in a rat heterotopic abdominal cardiac transplantation model (3, 4) . The combination of Lewis rat donors and F344 rat recipients results in long-term graft survival and a time-dependent development of arteriosclerotic lesions that resemble, on histologic examination, arteriosclerotic lesions in human transplant vessels (3, 4) . Immunohistochemical studies with antibodies against monocytes, T cells, and smooth muscle cells have shown that arteriosclerotic lesions develop in three distinct stages (5, 6 (7) .'
However, chronic cardiac rejection is likely to be a complex process mediated by a spectrum of factors. As an alternative to transcriptional analysis of selected known factors that could be involved in chronic rejection, we have used a modified differential mRNA display technique (8) to identify potential mediators that are novel or have not been previously implicated in chronic rejection. In the present in vivo analysis of intact organs, we compared transcript patterns from Lewis to F344 cardiac allografts affected by chronic rejection with those of Lewis cardiac syngrafts exposed to the same surgical procedure but normal on histologic examination. These investigations identified a macrophage lectin cDNA fragment that was specifically induced in cardiac allografts. The purpose of this study was to clone the full-length cDNA and analyze its transcriptional induction patterns in chronic cardiac rejection.
Methods
Lewis to F344 rat cardiac transplantation. Heterotopic abdominal cardiac transplantation was performed as described with Lewis donor hearts (4) in an allogeneic combination involving F344 recipients. The syngeneic combination involved Lewis recipients and was performed to assess the contribution of surgical manipulation to the inflammatory response. Lewis hearts that had been harvested but not transplanted were used as reference groups matching the strain of donor or grafted hearts. At the time of harvest, both the host (recipient) and the transplanted hearts were collected for histologic analysis and RNA extraction. The host heart served as a reference that had been exposed to the same circulation but was normal on histologic examination. In some studies, the host spleen was also harvested for a comparison of transcription patterns in an organ rich in inflammatory cells but free of local allogeneic stimulation. In this study we used hearts harvested at 7 and 14 d because at these points macrophage infiltration starts to become evident. Midventricular sections were taken for histologic analysis at the time of harvest and snap frozen in liquid nitrogen for RNA extraction.
RNA isolation and Northern analysis. We modified a published reverse transcriptase PCR technique developed to measure differences in monocyte chemoattractant protein-1 transcript levels (7) for use with Gal/GalNAc macrophage lectin. cDNA synthesis was completed with random primers (2.5 gg total RNA per reaction).
Oligonucleotides were synthesized by Genosys Biotechnologies (The Woodlands, TX). The sequences were CCT AGA AAC CCT GAG AAC for the 5' primer and GAG TGC CGC TTA TTG TAG for the 3' primer, chosen from the sequence analysis of our cDNA clone to result in a 941-bp product. Reaction conditions were as previously described. The thermal cycling parameters were denaturation at 94°C for 15 s, annealing at 54°C for 20 s, and extension for 60 s (with a final extension of 7 min at the end of all cycles). For semiquantitative PCR analyses, 150,000 cpm of 32P-dCTP was included in the PCR reaction. The products were separated on 1% agarose gels which were dried and exposed to PhosphorImaging screens for 12 h, and the amount of incorporated 32p in amplified product bands was then measured by volume integration (Imagequant software; Molecular Dynamics Inc., Sunnyvale, CA).
To identify the optimum PCR conditions for accurate measurement of gene transcript levels, we established the logarithmic assay range with respect to cycle number and starting template concentration against different dilutions of cDNA. We used 30 cycles to perform the cDNA dilution study. Subsequent measurements of Gal/GalNAc macrophage lectin transcript levels were then completed at 30 cycles and a starting cDNA dilution of 1.25 tll. PCR amplification for 22 cycles with G3PDH, a ubiquitously expressed gene, was used as a control to assess variations in total RNA or cDNA loading between samples.1 Corrected Gal/GalNAc macrophage lectin values were derived by dividing the measured amplified product value by the mean of the G3PDH value obtained for that cDNA from at least three analyses. PCR analyses were completed on each set of cDNAs at least four times. Results were subjected to MANOVA without replication. If a difference was significant, individual comparisons were made by the student's t test, corrected by the Bonferroni method. Although there were variations in absolute values derived from different experiments, relative differences between cDNA sets analyzed at the same time were preserved.
Comparison of corrected Gal/GalNAc macrophage lectin levels. Differences in corrected Gal/GalNAc macrophage lectin transcript levels were examined in four separate studies. The first study was completed to compare differences in transcript levels at various points after cardiac transplantation. The 10 cDNAs in this time-course study included samples from four cardiac allografts harvested 7, 14, 28, and 75 d after transplantation compared with one day-0 Lewis heart, a total of three paired host hearts from days 7, 14, and 28, and a day-14 Lewis syngraft with its paired host heart. The second cDNA analysis examined whether Gal/GaINAc macrophage lectin induction occurred systemi-2. Abbreviation used in this paper: Gal/GalNAc, galactose/N-acetylgalactosamine.
cally or locally. cDNA levels in the host spleen (a major source of inflammatory cells) were compared with those in the allografted heart. The six cDNAs analyzed were derived from two additional allogeneic cardiac transplants: one harvested at 7 d, the other at 28 d. At each time point we compared the cDNAs from the host heart, allografted heart, and the host spleen. The third cDNA study examined Gal/GaJNAc macrophage lectin gene expression in various populations of isolated rat inflammatory cells. Of the nine cDNAs studied, six were prepared from splenocytes (both adherent and nonadherent, each type stimulated with buffer, concanavalin A, and LPS/IFN-y), two from separate thioglycolate-elicited macrophage preparations, and one from a 14-day cardiac allograft. The fourth cDNA study compared gene expression in cultured Lewis rat bone marrow-derived macrophages stimulated with isolated cytokines or a mixed culture containing lymphocytes and macrophages stimulated with concanavalin A.
Inflammatory cell populations. Isolated splenocytes were obtained by sieving splenic tissue into DME medium (GIBCO BRL, Gaithersburg, MD) as described (9) . These cells were fractionated with FicollPaque (Pharmacia Fine Chemicals, Piscataway, NJ), and the mononuclear fraction was cultured at a density of 2-4 X 106 in a humidified incubator with 37 and 5% CO2. A lymphocyte-enriched cell population was obtained by harvesting nonadherent cells by gentle washing 1 h after plating or by nylon wool purification. We judged the adherent cells to be phagocyte enriched by the fact that 20% of them stained with anti-macrophage antibody ED1. In contrast, few of the nonadherent cells were ED1 positive. Where indicated LPS (100 ng/ml; Sigma Chemical Co., St. Louis, MO), rat IFN-y (100 U/ml; GIBCO-BRL), concanavalin A (2 ttg/ml; Sigma Chemical Co.), or buffer alone was added to isolated cell populations and the cells were harvested 4 h later. Peritoneal inflammatory rat macrophages were elicited with thioglycolate medium as described (10) . They were collected 4 d after induction of inflammation, separated on a Ficoll-Paque gradient, and plated at a density of 2 X 10. At least 90% of the adherent cells were judged to be macrophages by morphologic criteria and ED1 staining.
Bone marrow-derived macrophages were obtained by culturing cells obtained from the femurs of Lewis rats in medium containing murine colony stimulating factor-I (CSF-1 ) for 6-8 d as described ( 11 ). More than 95% of the cells stained positive for ED1 and were thus judged to be of a monocyte/macrophage lineage. Medium without CSF-1 was substituted for culture medium 24 h before stimulation with buffer, IFNy (100 U/ml), murine IL-2 (10 U/ml; Genzyme Corp., Cambridge, MA), 11L4 (10 U/ml; Genzyme Corp.), IL-6 (20 U/ml; Genzyme Corp.), or concanavalin A (2 ug/ml). Mixed cultures were obtained by combining F344 lymphocytes (nylon wool-isolated splenocytes) activated with concanavalin A (for 24 h) directly with bone marrow-derived macrophage cultures treated with (or without) concanavalin A. The lymphocyte/macrophage ratios were 3:5 and 1:1. Lymphocytes alone activated with concanavalin A were used as a control. After 48 h we harvested the adherent cells and concentrated them (in a cytospin apparatus) onto microscope slides for immunohistochemical staining, or we extracted total RNA for reverse transcriptase PCR analysis. We assured the quality of the RNA before cDNA preparation by inspecting ribosomal RNA after 1 /ig had been separated on a 3-mm agarose gel.
In situ hybridization and immunohistochemistry. We completed in situ hybridization as described (12) raised against rat hepatic lectin, it does cross react with Gal/GaINAc macrophage lectin (13) . Negative controls included omission of the primary antibody and use of another primary antibody. We also stained with antibody EDI (Serotec Ltd., Oxford, UK), which recognizes monocytes/macrophages.
Results
Differential expression ofa Gal/GalNAc macrophage lectin 3' fragment in allografts. We used differential display techniques to identify transcriptionally induced genes in a panel of cDNAs derived from syngeneic heart transplants in comparison with allogeneic heart transplants. Analysis of polyacrylamide gels containing randomly amplified PCR products obtained by using OPA 4 (AAT CGG GCT G) as a S' primer and T12VTC (where V included A, C, and G) as a 3' primer identified an -380-bp fragment in sample lanes from allogeneic hearts but not in those from syngeneic hearts (Fig. 1 A) . When the cDNA in these upregulated bands was harvested, reamplified, and used to probe Northern blots, an allograft-specific hybridization pattern was visible (Fig. 1 B) . Transcripts of 1.4 kb were identified in lanes 3-6, containing total RNA derived from four hearts after allogeneic transplantation, but not in lanes 1 and 2, containing RNA from two syngeneic transplants. RNA loading prior to transfer is shown in the ethidium-stained agarose gel (Fig. 1 C) . These findings confirmed the gene regulation pattern identified in the differential mRNA display analysis performed with the same panel of total RNAs. Northern analysis was then completed with total RNA obtained from an additional six allogeneic transplants (three each harvested at 7 and 14 d) and two syngeneic transplants (both harvested at 14 d). Fig. 2 5-7 and 14-16) containing allografted heart samples, in contrast with the lanes containing the six paired host-heart samples and the four syngeneic-heart samples (two hosts and two syngrafts). Taken together (Figs. 1 and 2 ), these findings indicate that the induction was not restricted to individual animals or procedures but occurred uniformly in Lewis to F344 cardiac transplantation.
Cloning of Gal/GalNAc macrophage lectin from a rat cardiac cDNA library. Direct cloning of the amplified PCR fragment harvested from the differential display gel produced a 380-bp insert. When this insert was used as a probe in Northern blot analysis it hybridized to transcripts of 1.4-kb (data not shown) in lanes containing RNA from cardiac allografts but not in lanes containing samples from the host hearts, again reproducing the pattern identified by the differential display analysis. To determine the identity of the full-length cDNA, we screened a cardiac allograft cDNA library (Stratagene) with the 380-bp cloned PCR fragment. Nine recombinants were identified, the largest of which was 1.4 kb. Sequence analysis of this fragment and homology searching revealed that the fragment was 99% identical to rat Gal/GaINAc macrophage lectin mRNA (GenBank accession number J05495) submitted by Ii et al. (14) . The J05495 cDNA had been cloned from a rat peritoneal macrophage cDNA library.
Characterization of Gal/GalNAc macrophage lectin gene expression with a full-length cDNA clone. We examined the specificity of Gal/GaINAc macrophage lectin gene expression by Northern blot analysis in various rat organs, particularly those known to contain resident mononuclear cells. Probing with our full-length Gal/GaINAc macrophage lectin cDNA, we observed strong hybridization only in lane 2 containing RNA from the 28-day cardiac allograft (Fig. 3) . We included the sample from the host spleen (lane 3) to determine whether Gal/GalNAc macrophage lectin transcripts were induced by a systemic effect on macrophages after transplantation. The sam- Reverse transcriptase PCR measurement of Gal/GalNAc macrophage lectin transcript levels. To have a more sensitive method of measuring Gal/GalNAc macrophage lectin transcripts, we developed a reverse transcriptase PCR assay using specific primers. We first determined the conditions at which the PCR amplification rate was logarithmic in order to avoid the amplification plateau at which the PCR product level is no longer proportional to the starting template level. Gal/GalNAc macrophage lectin gene amplification (Fig. 4) Figure 4 . Linear range of Gal/GaINAc macrophage lectin reverse transcriptase PCR assay. Rat cardiac allograft cDNA was amplified using specific Gal/GalNAc macrophage lectin primers and separated electrophoretically on 1% agarose gels. 32P incorporation in the PCR product band from dried gels was measured in Phosphorlmager units. The linear relationship between amplified Gal/GaINAc macrophage lectin product bands and PCR cycle (upper panel) or added cDNA (represented as the calculated amount of total RNA in the PCR reaction, lower panel, using 30 cycles) identified the assay range in which amplified product was proportional to the initial target mRNA.
approach was used to compare relative differences between samples from three separate cDNA panels.
Specific and localized increase in corrected Gal/GalNAc macrophage lectin levels in cardiac allografts. Fig. 5 A shows that corrected Gal/GaINAc macrophage lectin gene transcript levels increased significantly in cardiac allografts (black bars) at all points studied (days 7, 14, 28, and 75) in comparison with the three reference groups: a day-0 heart (black bar), paired host hearts (hatched bars) and syngrafts (shaded bars) (P < 0.008). The increase in transcript levels between day 0 and day 28 measured by reverse transcriptase PCR (Fig. 5 ) correlated with the increase in hybridization measured by Northern blot analysis (Fig. 3, lane 2 , RNA from a day-28 allograft). Differences between transcript levels at the various time points were not significant among allografts. This lack of a difference suggests that there was no further increase after the initial induc- Figure 5 . Time course and local nature of Gal/GalNAc macrophage lectin gene expression after allogeneic cardiac transplantation. Corrected levels were derived by normalizing Gal/GaINAc macrophage lectin reverse transcriptase PCR values after 30 cycles against those for the control gene, G3PDH, and are shown in relative units. (A) There was a significant increase in cardiac transplant (or allograft) cDNA at 7, 14, 28, and 75 days (black bars) after transplantation compared with cDNA from the day-0 heart (harvested but not transplanted), paired host hearts (hatched bars), and a 14-day syngraft (stippled bar) (P < 0.008). (B) Gal/GaINAc macrophage lectin levels increased significantly in the transplanted hearts (black bars) at both 7 and 28 days compared with the host spleens (rich in resident macrophages but not subject to local allogeneic stimulation) and the host hearts normal on histologic examination (P < 0.0001), demonstrating the local nature of gene induction. Data are plotted as means±SEM and represent four separate PCR analyses.
tion, which would be consistent with an ongoing or chronic stimulation.
To examine whether Gal/GalNAc macrophage lectin gene induction was systemically or locally regulated, we compared levels in cardiac allografts with those in host spleens-reasoning that the spleen would be a major source of macrophages but be free of direct exposure to stimuli obtained in allografted tissue. As Fig. 5 B shows, Gal/GaINAc macrophage lectin transcript levels increased significantly in the 7-and 28-day cardiac allografts (black bars) relative to host spleens and hearts (hatched bars) (P < 0.0001 ). The low transcript levels in the host spleens suggest that Gal/GalNAc macrophage lectin gene 726 Russell et al. induction in the cardiac allograft was due to local activation or stimulation.
Expression of Gal/GalNAc macrophage lectin mRNA in a subset ofmononuclear cells in cardiac allografts. We performed in situ hybridization to localize the cell types expressing Gal/ GalNAc macrophage lectin mRNA in cardiac allograft tissue. Positive hybridization to the antisense probe was visible in scattered mononuclear cells within inflammatory infiltrates in the interstitium and perivascular space (Fig. 6, A and B) , as evidenced by the clustering of silver grains (arrows). There was little hybridization to adjacent noninflammatory cells such as cardiac myocytes, or when the negative control, the sense RNA probe (Fig. 6, C and D) , was used in seriate sections. There was no significant hybridization of the antisense or sense probe to paired host hearts, which lacked inflammatory infiltrates (not shown). Previous immunohistochemical studies of such inflammatory infiltrates showed that they were composed predominantly of macrophages and a few T lymphocytes (6) .
Corrected Gal/GaINAc macrophage lectin transcript levels in isolated inflammatory macrophages. To determine the specific inflammatory cell type expressing Gal/GalNAc macrophage lectin mRNA, we measured transcript levels in various isolated rat inflammatory cells. Fig. 7 A shows that corrected transcript levels increased significantly only in thioglycolateelicited macrophages and cells from a day-14 cardiac allograft (P < 0.0001) compared with adherent (macrophage-enriched) splenocytes (stimulated with buffer, concanavalin A, and LPS/ IFN-y) and nonadherent (lymphocyte-enriched) splenocytes (stimulated with buffer, concanavalin A, and LPS/IFN-y). The identification of Gal/GalNAc macrophage lectin gene transcripts only in thioglycolate-elicited rat macrophages suggests that only certain conditions or certain macrophage subsets are associated with expression of this lectin.
We then used bone marrow-derived macrophages to identify inflammatory conditions that might upregulate lectin transcript levels in vitro. Fig. 7 B shows that Gal/GalNAc macrophage lectin transcripts were barely detectable in resting cells, as well as in those treated for 24 h with INF-y (100 U/ml), LPS (100 ng/ml), IL-2 (10 U/ml), IL-4 (10 U/ml), and IL-6 (20 U/ ml). We also found no induction of transcripts in additional studies completed with various doses of INF-y (1-1,000 U/ ml) at various periods of incubation (3-72 h). However, we were able to confirm that the macrophages had been activated by the INF-y because of a fivefold increase in the level of nitrite released into the conditioned medium (measured by the Greiss reaction, which reflects nitric oxide production; data not shown). Because these isolated agents did not induce expression of bone marrow-derived Gal/GalNAc macrophage lectin, we studied the effect of mixed cultures of lymphocytes and macrophages. We used the mixtures as a way of stimulating the variety of cell types present in cardiac allografts and thioglycolate-elicited peritoneal inflammatory cells-two tissues in which lectin transcripts have been observed. Fig. 7 B shows that lectin transcript levels increased significantly (P < 0.0001 ) in the mixed cultures of F344 lymphocytes and Lewis macrophages at ratios of 3:5 and 1:1. We detected no lectin transcripts in lymphocytes alone after treatment with concanavalin A (Fig.  7 B (Fig. 8 A) was seen in -60% of the cells with macrophage morphology in the mixed cultures of lymphocytes and macrophages stimulated with concanavalin A. These positive cells were generally larger, had eccentric nuclei, and > 95% of them stained positive for EDI (not shown), confirming that they were of a macrophage lineage. (The smaller EDl-negative cells likely represented the lymphocyte population.) Immunostaining of 7-and 28-day rat cardiac allografts identified a small subset of positive mononuclear cells, usually in the area of inflammatory infiltrates. There were clusters of faintly positive cells within interstitial infiltrates (Fig. 8  B) as well as occasional strongly positive cells in small vessels (Fig. 8 C) . Staining with the monocyte-macrophage marker EDl confirmed that many of the mononuclear cells were of macrophage lineage in the interstitium and vessel, as we showed previously (6) . No positive staining was identified in host spleens or hearts or if primary antibody was omitted. Also, there was a less intense but diffuse cytoplasmic staining in hepatocytes in liver sections (not shown).
Discussion
Restricted upregulation of Gal/GalNAc macrophage lectin. While looking for potential molecular mediators of chronic cardiac rejection by a differential gene screening method, we identified a gene that proved to be Gal/GalNAc macrophage lectin. The gene transcripts we identified were specifically localized to and upregulated within Lewis to F344 rat cardiac allografts. This upregulation occurred early (by day 7) during initial macrophage accumulation and was sustained through days 14, 28 , and 75, as would be expected for a chronic inflammatory state characterized by ongoing macrophage infiltration. In contrast, transcript levels were low in three reference groups: paired host hearts (exposed to the same circulation but normal on histologic examination), day-14 Lewis syngrafts (subject to the same surgical procedure but with matching host and recipient strains), and day-O Lewis hearts (harvested but not transplanted). Furthermore, the induction of Gal/GaINAc macrophage lectin mRNA occurred in a compartmental fashion restricted to the allografted tissue. Transcript elevation was not found in the matching host spleens (studied because they are a major source of macrophages but not subject to allogeneic stimulation), nor was it found in other organs rich in resident macrophages. This pattern is in keeping with the arteriosclerotic changes found in human cardiac transplants, which affect donor vessels but spare host vessels.
Using in situ hybridization and immunohistochemistry, we have demonstrated that a small subset of inflammatory cells (presumably macrophages) within the cardiac allograft express Gal/GalNAc macrophage lectin. In examining the specificity of Gal/GalNAc macrophage lectin gene expression in various isolated rat inflammatory cells in vitro, we found that this lectin was only present when macrophages were also exposed to thioglycolate-elicited lymphocytes or to lymphocytes in mixed culture with concanavalin A. Taken together, our in vivo and in vitro findings demonstrate that expression of Gal/GalNAc macrophage lectin was restricted to a specific population of inflammatory macrophages and suggest that this lectin is an inducible cell-surface receptor under tight regulatory control. 728 Russell et al. Characteristics of Gal/GalNAc macrophage lectin. Lectins are a family of cell-surface proteins that specifically and selectively bind to complex carbohydrates on apposing cells (16) . They have emerged as primary markers for cell recognition with clear functional roles. For example, interference with a lectin's binding to its apposing carbohydrate can disrupt bacterial and mononuclear cell attachment, tumor metastasis, and embryogenesis. Gal/GalNAc macrophage lectin falls into the category of C-type animal lectins characterized by calciumdependent activity and extracellular location. It has been studied independently by the laboratories of T. Osawa and T. Kawasaki, groups with divergent research interests. The Osawa group purified the murine lectin in an effort to identify the factor responsible for the tumor binding capacity it conferred to murine macrophages after stimulation with the antitumor streptococcal preparation OK-432 (17, 18) . They showed increased lectin expression on the stimulated macrophages compared with resting ones. Antibody against the murine lectin prevented macrophage binding to and killing of tumor cells. The Kawasaki group cloned rat macrophage lectin, which they also designated macrophage-asialoglycoprotein-binding protein (m-ASGP-BP), and performed comparisons with the extensively studied rat hepatic lectins (RHL) (14, 19, 20) . The Kawasaki group found that single-chain m-ASGP-BP forms homooligomeric receptors that bind and internalize ligand in a high-affinity fashion specific for Gal and GalNac ( 13) . Rat hepatic lectin is an endocytic receptor for deglycosylated serum glycoproteins. The major form, RHL1, has 59% identity with the macrophage lectin cDNA. The two minor forms, RHL2 and -3, have 45% identity. An interesting variation in the macrophage lectin protein is the 24-amino acid insertion that includes an Arg-Gly-Asp (RGD) sequence. Because RGD is an integrin recognition sequence, it is possible that Gal/GaINAc macrophage lectin also confers integrin-mediated cellular adhesion.
Potential roles of Gal/GalNAc macrophage lectin. A spectrum of cell-surface molecules (or receptors) is thought to control macrophage function (21, 22) . For example, integrin receptors such as CDlla/CD18 regulate integrin adhesion, and the mannose receptor (a macrophage lectin) is involved in endocytosis. Gal/GalNAc macrophage lectin may also fall into this receptor category given that it is specifically and locally upregulated in the context of a pathophysiologic process where the hallmark is monocyte/macrophage infiltration and arteriosclerosis. More 
